Curli-dependent amyloid generator (C-DAG) Amyloidogenicity Kit (VS45 Strain, pVS72, and pVS105) is a bacteria-based methodology for the rapid generation of amyloid aggregates of a given amyloidogenic protein.
Highlights
Kit Components
The curli-dependent amyloid generator (C-DAG) methodology takes advantage of the natural ability of E. coli cells to elaborate surface associated amyloid fibers known as curli. The major curli fiber sub-unit is the amyloidogenic protein CsgA, which is secreted from the cell under the control of an N-terminal signal sequence. The transfer of this signal sequence to the N-terminus of heterologous amyloidogenic proteins similarly directs their export to the cell surface, where they assemble as amyloid fibrils. Importantly, protein secretion through the curli export pathway facilitates acquisition of the amyloid fold specifically for proteins that have an inherent amyloid forming propensity.
From the laboratory of Ann Hochschild, PhD, Harvard University.
Part of The Investigator's Annexe program.
Catalog Number | Product | DataSheet | Size | AVAILABILITY | Price | Qty |
---|
Product Type: | Kit |
C-DAG Amyloidogenicity Kit Protocol
C-DAG Amyloidogenicity Kit QC Data
E. coli Exporter Strain VS45 (Cat. EF2002)
Organism: | Escherichia coli |
Genotype: | [derivative of strain MC4100] F-, [araD139]B/r, Δ(argF-lac)169, λ-, e14-, flhD5301, Δ(fruK-yeiR)725(fruA25), relA1, rpsL150(strR), rbsR22, Δ(fimB-fimE)632(::IS1), deoC1, Δ(csgBAC) [containing plasmid pVS76; cat, PlacUV5-csgG, pACYC184 ori; produces CsgG] |
Cell Line Name: | VS45 |
Competency: | MES (2-[N-morpholine]ethanesulfonic acid) chemical competent cells |
Antibiotic Resistance: | Streptomycin (encoded on chromosome), chloramphenicol (encoded on plasmid pVS76) |
Growth Medium: | LB liquid or agar media, supplemented with the appropriate antibiotics, at 37˚C. (See attached PDF for more information) |
Induction: | To induce the expression of csgG from plasmid pVS76, the growth medium is supplemented with 1 mM IPTG. To induce the expression of the fusion gene for export from the pExport plasmid, the growth medium is supplemented with 0.2% arabinose. |
Storage Temperature: | -80C |
Shipped: | Dry Ice |
pExport (pVS72) Positive Control Plasmid (Cat. EF2003)
Gene Insert Name: | pVS72: sup35[NM], encoding residues 1 – 253 |
Insert Size: | pVS72: 759 bp (sup35[NM]) |
Species: | sup35 coding sequence is of S. cerevisiae origin. The pExport plasmid is a derivative of a commonly used plasmid vector for cloning and protein expression in E. coli |
Fusion Proteins/Tags: | pVS72 encodes CsgAss-(Ala)3-Sup35[NM]-(His)6, where CsgAss is the CsgA secretion signal |
Vector Backbone and Size (bp): | pBR322 derivative: 5434 bp for pVS72 |
Cloning site 5' : | NotI (between csgAss and sup35[NM]) |
Cloning site 3' : | XbaI (immediately after the STOP codon) |
Antibiotic Resistance: | Ampicillin |
High or Low Copy: | High |
Grow in Standard E. coli @ 37C?: | Yes |
Selectable Markers: | None |
Storage Temperature: | -20C |
Shipped: | Room Temperature |
pExport (pVS105) Negative Control (Cat. EF2004)
Gene Insert Name: | pVS105: sup35[M], encoding residues 125 – 253 |
Insert Size: | pVS105: 387 bp (sup35[M]) |
Species: | sup35 coding sequence is of S. cerevisiae origin. The pExport plasmid is a derivative of a commonly used plasmid vector for cloning and protein expression in E. coli |
Fusion Proteins/Tags: | pVS105 encodes CsgAss-(Ala)3-Sup35[M]-(His)6, where CsgAss is the CsgA secretion signal |
Vector Backbone and Size (bp): | pBR322 derivative: 5062 bp for pVS105 |
Cloning site 5' : | NotI (between csgAss and sup35[M]) |
Cloning site 3' : | XbaI (immediately after the STOP codon) |
Antibiotic Resistance: | Ampicillin |
High or Low Copy: | High |
Grow in Standard E. coli @ 37C?: | Yes |
Selectable Markers: | None |
Storage Temperature: | -20C |
Shipped: | Room Temperature |
(LEFT) pExport plasmid map with relevant features. In the example above ,the pExport plasmid, pVS72, contains Sup35 NM as the gene of interest. All restriction sites shown are unique. (RIGHT) Results for Sup35 NM and Sup35 M when using C-DAG and tested in various assays. (A) When grown on solid medium supplemented with CR, E. coli cells producing CsgAss-NM form colonies that stain red, whereas cells producing CsgAss-M form pale colonies (reprinted, with permission, from ref. 5). (B) E. coli cells secreting CsgAss-NM produce fibrillar aggregates that can be visualized by transmission electron microscopy (TEM), whereas cells secreting CsgAss-M do not produce fibrillar aggregates. (C) The fibrillar aggregates generated by cells secreting CsgAss-NM are immunolabeled by a Sup35 antibody. No fibrillar aggregates are detected for cells secreting CsgAss-M (reprinted, with permission from ref. 5). (D) E. coli cells secreting CsgAss-NM produce material that manifests apple-green birefringence when viewed by bright-field microscopy between crossed polarizers, whereas cells secreting CsgAss-M do not. Cell samples are taken from colonies formed on solid medium supplemented with Congo Red. (E) SDS-resistant aggregates are detected using the filter-retention assay for samples of cells secreting CsgAss-NM, but not for cell samples secreting CsgAss-M.
Adapted from: Sivanathan V. & Hochschild A., Nat Prot. (2013) 8:1381-1390.
To replace sup35[NM] or sup35[M] with your gene of interest, PCR amplify your gene of interest using primers that provide the NotI and XbaI restriction sites, as well as the (His)6 tag and STOP codon, as described below and in ref(1):
Forward primer:
5' TATA GCG GCC GCA xxx ...., with xxx encoding the first codon of your gene of interest
GCG GCC GCA encodes the NotI restriction site as well as a (Ala)3 linker between the csgAss and your protein of interest
Reverse primer: (listed as the reverse complement of the coding strand)
5' TATA TCTAGA TTA gtgatgatggtgatggtg yyy ...., with yyy encoding the last codon of your gene of interest
TCTAGA encodes the XbaI restriction site
TTA encodes the STOP codon
gtgatgatggtgatggtg encodes (His)6
If you publish research with this product, please let us know so we can cite your paper.